AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$NNOX

Meltzer Erez purchased $11K of NNOX (indirect holdings)

Meltzer Erez (Chief Executive Officer) purchased 25,000 indirectly-held shares of Nano-X Imaging Ltd. (NNOX) at $0.45 on 2026-10-19.

Original reporting
SEC EDGAR · Meltzer Erez
Published Oct 20, 2026, 10:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 10:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$NNOX
Neutral
high confidence
Mentioned
$NNOX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NNOXNeutralLow
01

Why it matters

The filing provides a fresh data point on insider activity but does not alter the company's fundamentals.

02

Market read

A modest insider purchase with negligible effect on stock price or market perception.

03

What to watch

Insider ownership remains low; the buy does not change control dynamics.

Relevance 3/10Novelty 3/10Timing: post‑market filing today

Background

Form 4 filings disclose insider trades; small purchases are common and often have limited market impact.

Company-level read

Ticker impact

$NNOXNeutralHigh confidence
Context

CEO Meltzer Erez bought 25,000 shares for $11,250 in an open‑market purchase disclosed via a Form 4 filing.

Expected impact

likely minimal pressure as market absorbs a small buy order

Evidence & confidence

The transaction is small ($11k) and does not materially affect ownership or valuation.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

The purchase could be a routine portfolio rebalancing rather than a confidence signal.

Key entities

  • company
    Nano‑X Imaging Ltd.

    Medical imaging company listed on Nasdaq under NNOX.

  • person
    Meltzer Erez

    Chief Executive Officer of Nano‑X Imaging Ltd.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

NNOX insider trading history →

Related articles

$NNOXMed

Nano X Imaging Ltd (NNOX) (Q2 2026) Earnings Call Highlights: Re

Nano X Imaging Ltd (NNOX) reported a 37% year-over-year revenue increase in Q2 2026, driven by growth in teleradiology services and new partnerships. The company also announced operational streamlining and cost reductions. However, NNOX recorded a $40.7 million impairment charge, a significant decrease in cash position, and a widened net loss of $55.5 million. Management expects revenue traction in the coming months and potential market expansion due to new reimbursement codes.

gurufocus.com
$NNOXHigh

Nano-X Imaging Ltd. (NNOX): Financial results for Q2 2026

Nano-X Imaging Ltd. (NNOX) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates Management to host conference call and webcast on Wednesday, September 9, 2026 at 8:30 AM ET PETACH TIKVA, Israel — September 9, 2026 — NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or

SEC EDGAR 6-K
$NNOXMed

NANO-X IMAGING LTD: Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

Nanox Imaging Ltd (NASDAQ: NNOX) said its subsidiary Nanox AI entered an exclusive UK sales reseller agreement with Vertec Scientific for commercialization of Nanox.AI bone solution (HealthOST). The initial three-year term requires Vertec to meet minimum annual license commitments. HealthOST is FDA-cleared and UKCA/CE-marked and was recommended by NICE in Nov 2025 for NHS use.

finanznachrichten.de